Abbrea Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
$359K Sell
4,519
-558
-11% -$44.3K 0.05% 182
2024
Q1
$446K Buy
5,077
+125
+3% +$11K 0.06% 175
2023
Q4
$411K Sell
4,952
-1,230
-20% -$102K 0.06% 172
2023
Q3
$489K Sell
6,182
-45
-0.7% -$3.56K 0.08% 154
2023
Q2
$553K Buy
6,227
+551
+10% +$48.9K 0.09% 150
2023
Q1
$461K Buy
5,676
+643
+13% +$52.2K 0.08% 161
2022
Q4
$395K Sell
5,033
-1,270
-20% -$99.6K 0.07% 166
2022
Q3
$513K Sell
6,303
-329
-5% -$26.8K 0.1% 142
2022
Q2
$600K Buy
6,632
+112
+2% +$10.1K 0.1% 145
2022
Q1
$728K Buy
6,520
+395
+6% +$44.1K 0.1% 149
2021
Q4
$637K Sell
6,125
-340
-5% -$35.4K 0.09% 154
2021
Q3
$814K Sell
6,465
-160
-2% -$20.1K 0.12% 131
2021
Q2
$827K Sell
6,625
-84
-1% -$10.5K 0.12% 129
2021
Q1
$796K Buy
6,709
+94
+1% +$11.2K 0.13% 122
2020
Q4
$779K Buy
6,615
+400
+6% +$47.1K 0.14% 113
2020
Q3
$649K Sell
6,215
-317
-5% -$33.1K 0.14% 114
2020
Q2
$603K Sell
6,532
-273
-4% -$25.2K 0.14% 121
2020
Q1
$617K Sell
6,805
-285
-4% -$25.8K 0.16% 109
2019
Q4
$808K Buy
7,090
+290
+4% +$33K 0.17% 113
2019
Q3
$742K Buy
6,800
+690
+11% +$75.3K 0.17% 115
2019
Q2
$595K Buy
6,110
+1,771
+41% +$172K 0.15% 123
2019
Q1
$397K Sell
4,339
-45
-1% -$4.12K 0.11% 124
2018
Q4
$401K Buy
4,384
+128
+3% +$11.7K 0.13% 117
2018
Q3
$421K Buy
4,256
+220
+5% +$21.8K 0.12% 124
2018
Q2
$346K Buy
4,036
+120
+3% +$10.3K 0.11% 133
2018
Q1
$316K Buy
3,916
+238
+6% +$19.2K 0.1% 139
2017
Q4
$299K Sell
3,678
-41
-1% -$3.33K 0.1% 134
2017
Q3
$291K Buy
3,719
+55
+2% +$4.3K 0.11% 132
2017
Q2
$325K Buy
3,664
+195
+6% +$17.3K 0.13% 122
2017
Q1
$281K Buy
3,469
+45
+1% +$3.65K 0.11% 126
2016
Q4
$244K Buy
+3,424
New +$244K 0.11% 125